Current epidemiological data estimate that one in five people suffers from chronic pain with
considerable impairment of health-related quality of life. The pharmacological treatment is …

Sarcopenia has a significant impact on falls, physical function, activities of daily living, and
quality of life in older adults, and its prevention and treatment are becoming increasingly …

In autoimmune neurological diseases, the autonomic nervous system can be the primary
target of autoimmunity (eg autoimmune autonomic ganglionopathy), or, more frequently, be …

Neurological immune-related adverse events (irAEs) due to immune checkpoint inhibitors
(ICI) are rare complications of immunotherapy, particularly dreadful for patients and clinical …

Since the approval for the treatment of melanoma in 2014, immune checkpoint inhibitors
(ICIs) have revolutionized the therapy pattern across various malignancies. Coinciding with …

The use of immune checkpoint inhibitors (ICIs) for the treatment of various advanced and
aggressive types of malignancy has significantly increased both survival and long-term …

The increasing use of immune checkpoint inhibitors (ICI) in cancer therapy has brought
attention to their associated neurotoxicities, termed neurological immune-related adverse …

Rare side effects of immune-checkpoint inhibitors (ICIs) are known as neurological immune-
related adverse events (n-irAEs). Typically, n-irAEs affect the peripheral nervous system …

The objective of our study is to analyze the occurrence of neurologic events with ICIs.
Methods: We referred to EudraVigilance (EV) and VigiAccess to evaluate the frequency of …

Immune checkpoint inhibitors (ICIs) are a group of drugs that have improved outcomes for
patients with various cancers. Generally considered safe and well tolerated, these drugs are …